167 related articles for article (PubMed ID: 12676451)
1. Regulatory recognition of indirect genotoxicity mechanisms in the European Union.
Pratt IS; Barron T
Toxicol Lett; 2003 Apr; 140-141():53-62. PubMed ID: 12676451
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
3. Threshold-mediated mechanisms in mutagenesis: implications in the classification and regulation of chemical mutagens.
Crebelli R
Mutat Res; 2000 Jan; 464(1):129-35. PubMed ID: 10633185
[TBL] [Abstract][Full Text] [Related]
4. Threshold effects in genetic toxicity: perspective of chemicals regulation in Germany.
Madle S; von der Hude W; Broschinski L; Jänig G
Mutat Res; 2000 Jan; 464(1):117-21. PubMed ID: 10633183
[TBL] [Abstract][Full Text] [Related]
5. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
6. Reflections on the implications of thresholds of mutagenic activity for the labelling of chemicals by the European Union.
Parry JM
Mutat Res; 2000 Jan; 464(1):155-8. PubMed ID: 10633188
[TBL] [Abstract][Full Text] [Related]
7. Impact of DNA polymerase ζ mutations on genotoxic thresholds of oxidative mutagens.
Suzuki T; Matsumoto K; Honma M; Nohmi T
Mutat Res Genet Toxicol Environ Mutagen; 2018 Apr; 828():10-14. PubMed ID: 29555059
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds.
Kirkland DJ; Müller L
Mutat Res; 2000 Jan; 464(1):137-47. PubMed ID: 10633186
[TBL] [Abstract][Full Text] [Related]
9. Research on the mechanisms of action of aneugenic chemicals and regulatory approaches for their control in the European Communities.
Parry JM
Environ Mol Mutagen; 1996; 28(3):248-53. PubMed ID: 8908183
[TBL] [Abstract][Full Text] [Related]
10. Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals.
Müller L; Kasper P
Mutat Res; 2000 Jan; 464(1):19-34. PubMed ID: 10633174
[TBL] [Abstract][Full Text] [Related]
11. Thresholds in genotoxicity responses.
Henderson L; Albertini S; Aardema M
Mutat Res; 2000 Jan; 464(1):123-8. PubMed ID: 10633184
[TBL] [Abstract][Full Text] [Related]
12. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
13. Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the in vitro modified comet assay: determination of No-Observed-Genotoxic-Effect-Levels.
Platel A; Nesslany F; Gervais V; Claude N; Marzin D
Mutat Res; 2011 Dec; 726(2):151-9. PubMed ID: 21930235
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.
Parry JM; Jenkins GJ; Haddad F; Bourner R; Parry EM
Mutat Res; 2000 Jan; 464(1):53-63. PubMed ID: 10633177
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
16. An integrative test strategy for cancer hazard identification.
Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
[TBL] [Abstract][Full Text] [Related]
17. Indirect mechanisms of genotoxicity.
Kirsch-Volders M; Vanhauwaert A; Eichenlaub-Ritter U; Decordier I
Toxicol Lett; 2003 Apr; 140-141():63-74. PubMed ID: 12676452
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the potential germ cell mutagenicity of industrial and plant protection chemicals as part of an integrated study of genotoxicity in vitro and in vivo.
Arni P; Ashby J; Castellino S; Engelhardt G; Herbold BA; Priston RA; Bontinck WJ
Mutat Res; 1988 Jun; 203(3):177-84. PubMed ID: 3287152
[TBL] [Abstract][Full Text] [Related]
19. Application of the TGx-28.65 transcriptomic biomarker to classify genotoxic and non-genotoxic chemicals in human TK6 cells in the presence of rat liver S9.
Yauk CL; Buick JK; Williams A; Swartz CD; Recio L; Li HH; Fornace AJ; Thomson EM; Aubrecht J
Environ Mol Mutagen; 2016 May; 57(4):243-60. PubMed ID: 26946220
[TBL] [Abstract][Full Text] [Related]
20. Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells.
Mizota T; Ohno K; Yamada T
Mutat Res; 2011 Sep; 724(1-2):76-85. PubMed ID: 21704725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
